HCA Healthcare, Inc. $HCA Shares Purchased by Illinois Municipal Retirement Fund

Illinois Municipal Retirement Fund grew its stake in HCA Healthcare, Inc. (NYSE:HCA) by 2.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 11,117 shares of the company’s stock after purchasing an additional 287 shares during the period. Illinois Municipal Retirement Fund’s holdings in HCA Healthcare were worth $4,259,000 at the end of the most recent quarter.

A number of other large investors have also modified their holdings of HCA. ProShare Advisors LLC increased its stake in shares of HCA Healthcare by 6.8% in the 2nd quarter. ProShare Advisors LLC now owns 30,844 shares of the company’s stock valued at $11,816,000 after purchasing an additional 1,960 shares in the last quarter. PFG Advisors raised its position in HCA Healthcare by 4.9% during the second quarter. PFG Advisors now owns 1,879 shares of the company’s stock worth $720,000 after acquiring an additional 87 shares during the period. Zions Bancorporation National Association UT increased its stake in shares of HCA Healthcare by 49.3% during the second quarter. Zions Bancorporation National Association UT now owns 424 shares of the company’s stock worth $162,000 after purchasing an additional 140 shares in the last quarter. Midwest Trust Co acquired a new stake in HCA Healthcare in the 2nd quarter worth about $342,000. Finally, Acadian Asset Management LLC boosted its stake in shares of HCA Healthcare by 12,084.6% in the second quarter. Acadian Asset Management LLC now owns 77,738 shares of the company’s stock worth $29,780,000 after acquiring an additional 77,100 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Trading Up 2.5%

NYSE:HCA opened at $474.08 on Thursday. The stock has a fifty day moving average price of $431.29 and a 200 day moving average price of $394.54. The firm has a market cap of $108.18 billion, a PE ratio of 18.33, a price-to-earnings-growth ratio of 1.38 and a beta of 1.41. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $479.43.

HCA Healthcare (NYSE:HCA) last released its earnings results on Friday, October 24th. The company reported $6.96 earnings per share for the quarter, topping analysts’ consensus estimates of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The firm had revenue of $19.16 billion for the quarter, compared to analyst estimates of $18.55 billion. During the same period in the prior year, the firm earned $4.90 earnings per share. The business’s quarterly revenue was up 9.6% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. Equities analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be issued a $0.72 dividend. The ex-dividend date is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 11.13%.

Insider Buying and Selling

In other news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction dated Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the completion of the sale, the executive vice president directly owned 3,487 shares of the company’s stock, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president directly owned 31,503 shares of the company’s stock, valued at $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.30% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities research analysts have recently commented on HCA shares. Sanford C. Bernstein reiterated a “market perform” rating and issued a $417.00 target price on shares of HCA Healthcare in a research report on Monday, October 27th. Raymond James Financial set a $525.00 target price on shares of HCA Healthcare in a research note on Monday, October 27th. Truist Financial upped their price objective on HCA Healthcare from $460.00 to $495.00 and gave the company a “buy” rating in a report on Monday, October 27th. Morgan Stanley set a $425.00 price target on HCA Healthcare in a research note on Monday, October 27th. Finally, Jefferies Financial Group upped their target price on shares of HCA Healthcare from $485.00 to $525.00 and gave the company a “buy” rating in a research report on Tuesday, October 28th. One research analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and ten have assigned a Hold rating to the stock. Based on data from MarketBeat, HCA Healthcare currently has a consensus rating of “Moderate Buy” and an average price target of $473.53.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.